Photon-Counting CT for Detection of Small Gastrointestinal Lesions
PCCT-GI
1 other identifier
observational
1,762
1 country
1
Brief Summary
This comparative matched-cohort study aims to evaluate the diagnostic performance of contrast-enhanced photon-counting computed tomography (PCCT) for detecting small gastrointestinal lesions compared with energy-integrating detector dual-energy computed tomography (DECT). The study includes a prospectively enrolled PCCT cohort and a retrospectively identified DECT cohort. Endoscopy with histopathology serves as the reference standard. Primary evaluation focuses on lesion detection, with additional assessment of lesion characterization, image quality, quantitative imaging parameters, and interobserver agreement.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 18, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 9, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
May 21, 2026
CompletedFirst Submitted
Initial submission to the registry
July 12, 2026
CompletedFirst Posted
Study publicly available on registry
August 6, 2026
CompletedAugust 6, 2026
June 1, 2026
2.3 years
July 12, 2026
August 1, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Lesion-Based Detection Rate
Lesion-based detection rate of contrast-enhanced photon-counting CT compared with energy-integrating detector dual-energy CT using endoscopy with histopathology, when available, as the reference standard.
During the study period (January 2026 - March 2026)
Secondary Outcomes (10)
Positive Predictive Value of CT-Positive Findings
During the study period (March 2026 to June 2026)
Yield of Clinically Actionable Lesions
During the study period (March 2026 to June 2026)
Lesion-to-Mucosa Attenuation Difference
During the study period (January 2026 - March 2026)
Image Noise
During the study period (January 2026 - March 2026)
Signal-to-Noise Ratio
During the study period (January 2026 - March 2026)
- +5 more secondary outcomes
Study Arms (3)
PCCT Diagnostic Cohort
Prospectively enrolled adults who underwent contrast-enhanced photon-counting computed tomography (PCCT) for evaluation of suspected small gastrointestinal lesions. Patients meeting the eligibility criteria were included in the diagnostic performance cohort and subsequently matched 1:1 with the retrospective DECT cohort using propensity score matching.
DECT Diagnostic Cohort
Retrospectively identified adults who underwent contrast-enhanced energy-integrating detector dual-energy computed tomography (DECT) for evaluation of suspected small gastrointestinal lesions. Eligible patients were matched 1:1 with the prospective PCCT cohort using propensity score matching for diagnostic performance comparison.
Prospective Clinical Implementation Cohort
Consecutive adults undergoing routine contrast-enhanced abdominal photon-counting computed tomography (PCCT) in clinical practice. Patients with CT-positive findings suggestive of small gastrointestinal lesions were referred for endoscopy when appropriate to evaluate the clinical implementation of PCCT.
Interventions
Contrast-enhanced abdominal photon-counting computed tomography performed for the detection and characterization of small gastrointestinal lesions.
Contrast-enhanced abdominal energy-integrating detector dual-energy computed tomography performed for comparison of diagnostic performance in detecting and characterizing small gastrointestinal lesions.
Eligibility Criteria
This study includes two cohorts: a retrospective diagnostic-performance cohort and a prospective clinical implementation cohort. Patients underwent contrast-enhanced photon-counting CT (PCCT) or energy-integrating detector dual-energy CT (DECT) for evaluation of suspected small gastrointestinal lesions in a clinical setting.
You may qualify if:
- Adults aged 18-80 years.
- Patients undergoing contrast-enhanced abdominal CT (photon-counting CT or energy-integrating detector dual-energy CT).
- At least one endoscopically detected or clinically suspected small gastrointestinal lesion.
- Lesions confirmed or suspected on endoscopy, pathology, or follow-up imaging.
- Lesions characterized as mucosal thickening or nodular lesions within predefined size criteria (≤2 cm).
You may not qualify if:
- Prior gastrointestinal surgery affecting target evaluation region.
- Poor or nondiagnostic CT image quality.
- Incomplete or unavailable endoscopic or histopathological reference standard.
- Ambiguous lesion localization on endoscopy or imaging.
- Severe motion artifacts or inadequate bowel distension affecting diagnostic evaluation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Second Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, 400010, China
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Target Duration
- 1 Month
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 12, 2026
First Posted
August 6, 2026
Study Start
September 18, 2023
Primary Completion
January 9, 2026
Study Completion
May 21, 2026
Last Updated
August 6, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will not share
This study is an observational diagnostic accuracy study based on routinely collected clinical imaging and endoscopic data. Individual participant data will not be publicly shared due to patient privacy protection and institutional data governance restrictions. Only aggregated results will be reported in publications.